Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

    Misbah Noshela Ghazanfar, Simon Francis Thomsen
    Studysummary This case report details a young female patient's experience of transient hair loss after starting omalizumab (anti-IgE) for chronic urticaria, noting that she continued the treatment for 10 months with positive outcomes despite this side effect.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eurannallergyimm.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Neural Mechanisms of Hair Growth Control Journal of Investigative Dermatology Symposium Proceedings · 1997